Chemical and biological characterization of the lipopolysaccharide of Bacteroides fragilis subspecies fragilis. 1976

D L Kasper

Bacterial lipopolysaccharides extracted from Bacteroides fragilis subspecies fragilis lacked 2-keto-3-deoxyoctonate and heptose, sugars which make up part of the inner core of most bacterial endotoxins. Over 98% of the lipid portion of this material could be removed easily with chloroform-methanol and alcohol, a finding which indicates a loose association between the polysaccharide and lipid moieties. The lipopolysaccharides caused gelation of limulus lysate at a concentration significantly higher than that for the endotoxin of Salmonella typhi. None of the extracts was lethal in 10-day-old chick embryos at doses of greater than 200 mug per egg, whereas the endotoxin of Neisseria meningitidis was lethal at a dose of 1.2 mug per egg. The local Shwartzman reaction could not be induced by levels of B. fragilis endotoxin of up to 1,000 mug per rabbit, whereas a (control) endotoxin of S. typhi induced this phenomenon at a level of 3 mug per rabbit. Intact oxygen-killed B. fragilis failed to provoke the local Shwartzman reaction at doses of 2,500 mug. These results indicate that B. fragilis has a lipopolysaccharide different from that of most gram-negative bacteria. Although it retains some of the chemical and biologic properties of classical endotoxin, it seems to lack others. This observation may have significant clinical implications.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D006539 Heptoses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001099 Arachnoid A delicate membrane enveloping the brain and spinal cord. It lies between the PIA MATER and the DURA MATER. It is separated from the pia mater by the subarachnoid cavity which is filled with CEREBROSPINAL FLUID. Arachnoid Mater,Arachnoid Maters,Arachnoids
D001439 Bacteroides A genus of gram-negative, anaerobic, rod-shaped bacteria. Its organisms are normal inhabitants of the oral, respiratory, intestinal, and urogenital cavities of humans, animals, and insects. Some species may be pathogenic.
D012790 Shwartzman Phenomenon Hemorrhagic necrosis that was first demonstrated in rabbits with a two-step reaction, an initial local (intradermal) or general (intravenous) injection of a priming endotoxin (ENDOTOXINS) followed by a second intravenous endotoxin injection (provoking agent) 24 h later. The acute inflammation damages the small blood vessels. The following intravascular coagulation leads to capillary and venous THROMBOSIS and NECROSIS. Shwartzman phenomenon can also occur in other species with a single injection of a provoking agent, and during infections or pregnancy. Its susceptibility depends on the status of IMMUNE SYSTEM, coagulation, FIBRINOLYSIS, and blood flow. Schwartzman Phenomenon,Shwartzman Reaction,Schwartzman Reaction,Phenomenon, Schwartzman,Phenomenon, Shwartzman,Schwartzman Reactions
D014020 Tissue Extracts Preparations made from animal tissues or organs (ANIMAL STRUCTURES). They usually contain many components, any one of which may be pharmacologically or physiologically active. Tissue extracts may contain specific, but uncharacterized factors or proteins with specific actions. Extracts, Tissue

Related Publications

D L Kasper
July 1978, The Journal of antimicrobial chemotherapy,
D L Kasper
March 1976, Antimicrobial agents and chemotherapy,
D L Kasper
January 1979, Reviews of infectious diseases,
D L Kasper
September 1984, Journal of clinical microbiology,
D L Kasper
January 1993, Medycyna doswiadczalna i mikrobiologia,
D L Kasper
February 1985, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology,
D L Kasper
January 1977, Bulletin de l'Academie polonaise des sciences. Serie des sciences biologiques,
Copied contents to your clipboard!